Ynno Med Limited

Ynno Med is a drug R&D platform dedicated to addressing the unmet clinical needs of new antimicrobial agents tackling antimicrobial resistance. We have established a cutting-edge antibiotic discovery platform that targets unprecedented drug targets, specifically protein-protein interactions involved in bacterial RNA synthesis. Our goal is to design, develop, and distribute first-in-class antimicrobial medicines that can treat current antibiotic-resistant bacterial infections and suppress the generation of new antimicrobial resistance. We also provide drug design and discovery services through our AI-assisted drug discovery technologies.